Health care stocks were flat to higher premarket Thursday, with The Health Care Select Sector SPDR Fund (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) inactive.
Soleno Therapeutics (SLNO) shares were up 35% after the company said overnight that the US Food and Drug Administration has approved its treatment for hyperphagia in adults and children with Prader-Willi Syndrome, a rare genetic disorder.
Bausch + Lomb (BLCO) stock was more than 4% lower after the company said it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.
Ascentage Pharma Group (AAPG) shares were up over 10% after the company reported a narrower 2024 loss as revenue rose during the period.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。